GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals: Independent Director Navin Kumar retires

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 22 Jun 2026, 04:40 PM IST  ·  BSE ID: b7dc0a1e-1b09-439a-9ebe-8ddfb4419ccb
View Original BSE Filing (PDF)
💡
In Simple Terms
An independent director is leaving the company's board after finishing his term, leading to changes in committee leadership.
🤖 AI Summary
  • Mr. Navin Kumar retires as Independent Director effective June 22, 2026.
  • He also ceases to chair the Audit and Nomination & Remuneration Committees.
  • Board committees, Audit and N&R, re-constituted effective June 23, 2026.
  • New committee compositions include Mr. P.K. Sundaresan as Chairman for both.
🏢 How This Affects the Company
⚙️
Operational Impact
The composition of the Audit Committee and Nomination & Remuneration Committee has changed, impacting governance oversight.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this director's retirement.
👤
Who Is Affected
All shareholders are indirectly affected by changes in board committee composition, which oversees governance and remuneration.
🔍
Management Signal
The retirement signals adherence to director term limits and routine board governance procedures.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Next board meeting announcement for any new director appointments.
Minutes of re-constituted committee meetings for strategic direction.
Annual report for detailed committee member profiles and duties.
LOW RISK Standard director retirement and committee re-constitution are routine governance actions.
💡 Investor Takeaway
Mr. Navin Kumar's tenure as Independent Director at Bafna Pharmaceuticals concluded on June 22, 2026, following the completion of his first term, prompting committee re-composition.
❓ Frequently Asked Questions
When did Mr. Navin Kumar retire as Independent Director of Bafna Pharmaceuticals?
Mr. Navin Kumar retired as Independent Director of Bafna Pharmaceuticals effective from close of business hours on June 22, 2026.
Which committees did Mr. Navin Kumar chair at Bafna Pharmaceuticals?
Mr. Navin Kumar ceased to be the Chairman of the Audit Committee and the Nomination & Remuneration Committee of Bafna Pharmaceuticals.
When were the Audit and Nomination & Remuneration Committees of Bafna Pharmaceuticals re-constituted?
The Audit Committee and the Nomination & Remuneration Committee of Bafna Pharmaceuticals were re-constituted with effect from June 23, 2026.
Who is the new Chairman of the Audit Committee at Bafna Pharmaceuticals?
Mr. Palamadai Krishnan Sundaresan is the new Chairman of the Audit Committee, effective June 23, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.